amikacin has been researched along with muramidase in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertelli, A; Bertelli, AA; Cirami, C; Giovannini, L; Marchitiello, M; Palla, R; Tuoni, M | 1 |
| Arakawa, H; Ishizuka, M; Naito, K; Okura, A; Takeuchi, T; Umezawa, H; Watanabe, Y | 1 |
| Hayasaka, S; Shiono, T | 1 |
| Hu, ST; Lai, HC; Liau, JR; Lin, CH; Shen, GH; Tsai, SH | 1 |
| Boles, LR; Bumgardner, JD; Fujiwara, T; Guerra, FD; Haggard, WO; Jennings, JA | 1 |
1 trial(s) available for amikacin and muramidase
| Article | Year |
|---|---|
Enzymuria in aminoglycoside-induced kidney damage. Comparative study of gentamicin, amikacin, sisomicin and netilmicin.
Topics: Adolescent; Adult; Aged; alpha-Glucosidases; Amikacin; Creatinine; Female; gamma-Glutamyltransferase; Gentamicins; Glucosidases; Humans; Kanamycin; Kidney; Male; Middle Aged; Muramidase; Netilmicin; Proteinuria; Sisomicin; Urinary Tract Infections | 1985 |
4 other study(ies) available for amikacin and muramidase
| Article | Year |
|---|---|
Protective effect of forphenicinol, a low molecular weight immunomodifier, against infection with Pseudomonas aeruginosa in mice and its mechanisms.
Topics: Adjuvants, Immunologic; Amikacin; Animals; Female; Glycine; Mice; Mice, Inbred ICR; Muramidase; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Superoxides | 1987 |
Aminoglycoside antibiotics and lysosomal enzymes of human tears.
Topics: Acetylglucosaminidase; Acid Phosphatase; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Depression, Chemical; Dibekacin; Erythromycin; Gentamicins; Hexosaminidases; Humans; Kanamycin; Muramidase; Sulbenicillin; Tears; Tobramycin | 1985 |
Mab_3168c, a putative acetyltransferase, enhances adherence, intracellular survival and antimicrobial resistance of Mycobacterium abscessus.
Topics: Acetyltransferases; Amikacin; Anti-Infective Agents; Biofilms; Computational Biology; Drug Resistance, Microbial; Hydrophobic and Hydrophilic Interactions; Macrophages; Muramidase; Mutation; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Promoter Regions, Genetic | 2013 |
Characterization of trimethyl chitosan/polyethylene glycol derivatized chitosan blend as an injectable and degradable antimicrobial delivery system.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Chitosan; Drug Carriers; Injections; Materials Testing; Mice; Muramidase; NIH 3T3 Cells; Polyethylene Glycols; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin; Viscosity | 2019 |